BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
35 results:

  • 1. Rescue of GM3 synthase deficiency by spatially controlled, rAAV-mediated ST3GAL5 delivery.
    Yang H; Brown RH; Wang D; Strauss KA; Gao G
    JCI Insight; 2023 May; 8(9):. PubMed ID: 37014712
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.
    Scholl JN; Weber AF; Dias CK; Lima VP; Grun LK; Zambonin D; Anzolin E; Dos Santos Dias WW; Kus WP; Barbé-Tuana F; Battastini AMO; Worm PV; Figueiró F
    Purinergic Signal; 2024 Feb; 20(1):47-64. PubMed ID: 36964277
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
    Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
    Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal cancer].
    Tsujio G; Muguruma K; Eguchi S; Iseki Y; Miki Y; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Nagahara H; Toyokawa T; Tanaka H; Lee S; Yashiro M; Ohira M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2073-2075. PubMed ID: 35045497
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors
    Amano M; Yedidi RS; Salcedo-Gómez PM; Hayashi H; Hasegawa K; Martyr CD; Ghosh AK; Mitsuya H
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0171521. PubMed ID: 34978889
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Glioma escape signature and clonal development under immune pressure.
    Maire CL; Mohme M; Bockmayr M; Fita KD; Riecken K; Börnigen D; Alawi M; Failla A; Kolbe K; Zapf S; Holz M; Neumann K; Dührsen L; Lange T; Fehse B; Westphal M; Lamszus K
    J Clin Invest; 2020 Oct; 130(10):5257-5271. PubMed ID: 32603315
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network.
    Soussain C; Choquet S; Blonski M; Leclercq D; Houillier C; Rezai K; Bijou F; Houot R; Boyle E; Gressin R; Nicolas-Virelizier E; Barrie M; Moluçon-Chabrot C; Lelez ML; Clavert A; Coisy S; Leruez S; Touitou V; Cassoux N; Daniau M; Ertault de la Bretonnière M; El Yamani A; Ghesquières H; Hoang-Xuan K
    Eur J Cancer; 2019 Aug; 117():121-130. PubMed ID: 31279304
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. FOXP1-induced lncRNA CLRN1-AS1 acts as a tumor suppressor in pituitary prolactinoma by repressing the autophagy via inactivating Wnt/β-catenin signaling pathway.
    Wang C; Tan C; Wen Y; Zhang D; Li G; Chang L; Su J; Wang X
    Cell Death Dis; 2019 Jun; 10(7):499. PubMed ID: 31235696
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation.
    Brace KM; Lee WW; Cole PD; Sussman ES
    J Clin Exp Neuropsychol; 2019 Oct; 41(8):814-831. PubMed ID: 31156064
    [No Abstract]    [Full Text] [Related]  

  • 10. Repurposing Disulfiram as An Anti-cancer Agent: Updated Review on Literature and Patents.
    Ekinci E; Rohondia S; Khan R; Dou QP
    Recent Pat Anticancer Drug Discov; 2019; 14(2):113-132. PubMed ID: 31084595
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [A Case of cancerous Meningitis in Juvenile Onset Gastric cancer].
    Kamada Y; Kamiya H; Kambe K; Iguchi M; Nagata T; Fukuda K; Iwata G; Yamaoka N; Tsukamoto K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1958-1960. PubMed ID: 30692410
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.
    Bagley SJ; Hwang WT; Brem S; Linette GP; O'Rourke DM; Desai AS
    J Neurooncol; 2019 Jan; 141(1):95-102. PubMed ID: 30353265
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System.
    Solomon IH; Li H; Benson LA; Henderson LA; Degar BA; Gorman MP; Duncan CN; Lidov HG; Alexandrescu S
    J Neuropathol Exp Neurol; 2018 Dec; 77(12):1079-1084. PubMed ID: 30295794
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. To prep or not to prep - that is the question: A randomized trial on the use of antiflatulent medication as part of bowel preparation for patients having image guided external beam radiation therapy to the prostate.
    McGuffin M; Devji N; Kehoe L; Carty A; Russell S; Di Prospero L; DeAngelis C; Kiss A; Vesprini D; Loblaw A; D'Alimonte L
    Pract Radiat Oncol; 2018; 8(2):116-122. PubMed ID: 29329996
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effects of water, sanitation, handwashing, and nutritional interventions on telomere length among children in a cluster-randomized controlled trial in rural Bangladesh.
    Lin A; Arnold BF; Mertens AN; Lin J; Benjamin-Chung J; Ali S; Hubbard AE; Stewart CP; Shoab AK; Rahman MZ; Hossen MS; Mutsuddi P; Famida SL; Akther S; Rahman M; Unicomb L; Dhabhar FS; Fernald LCH; Colford JM; Luby SP
    Elife; 2017 Oct; 6():. PubMed ID: 28980942
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Preoperative Coiling of Coexisting Intracranial Aneurysm and Subsequent brain Tumor Surgery.
    Park KY; Kim BM; Kim DJ
    Korean J Radiol; 2016; 17(6):931-939. PubMed ID: 27833409
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Purinergic Signalling and Neurological Diseases: An Update.
    Burnstock G
    CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma.
    Cui R; Guan Y; Sun C; Chen L; Bao Y; Li G; Qiu B; Meng X; Pang C; Wang Y
    Cancer Lett; 2016 Apr; 374(1):1-11. PubMed ID: 26854715
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
    D'Alimonte I; Nargi E; Zuccarini M; Lanuti P; Di Iorio P; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Ciccarelli R
    Purinergic Signal; 2015 Sep; 11(3):331-46. PubMed ID: 25976165
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary lymphoma of the brain in a young man whose brother died of hemophagocytic lymphohistiocytosis: case report.
    Džoljić E; Stošić-Opinćal T; Skender-Gazibara M; Terzić T; Mihaljević B; Milivojević G; Kostić V
    Srp Arh Celok Lek; 2015; 143(1-2):63-7. PubMed ID: 25845254
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.